(7-Azabenzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate

We are (7-Azabenzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate CAS:156311-83-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(7-Azabenzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate
CAS.NO:156311-83-0
Synonyms:tripyrrolidin-1-yl(triazolo[4,5-b]pyridin-3-yloxy)phosphanium,hexafluorophosphate;PyAOP
Molecular Formula:C17H27F6N7OP2
Molecular Weight:521.38100
 
Physical and Chemical Properties:
Melting point:163-168oC;
 
Specification:
Appearance:Off-white to white crystalline powder
Purity(HPLC):≥98.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As a condensation reagent
 

(7-Azabenzotriazol-1-yloxy)tripyrrolidinophosphonium hexafluorophosphate


Related News: The cell product candidate is being developed under a collaboration with Memorial Sloan Kettering Cancer Center (MSK) led by Michel Sadelain, MD, PhD.74853-08-0 The risk-based score generated by the tool helps sponsors gain advance understanding of the appropriate level of clinical supply management oversight needed to help get their project started on time and maintain momentum as the study progresses.65-82-7 It is foreseeable that in the future, the capacity and output of bulk APIs in China will decrease, the supply-demand relationship will be balanced, and prices and profits will gradually return to a more reasonable range. The era of low prices in the past will be gone forever. Individual APIs Varieties may even lose their price competitive advantage and move abroad.4-Chloro-3-nitrobenzenesulfonamide The company’s short-term plan is to move from a purely chemical intermediate manufacturer to a formula active material supplier, and its long-term goal is to become a solution provider in the selected segment. In the future, this business is expected to become a new growth point for the company’s profit.China has granted conditional approval to its first self-developed treatment for Alzheimer’s disease, a move that may point to revived opportunities in a therapeutic area where drugmakers have burned billions of dollars without yielding a validated new drug.

Related Products
Product Name
5-Bromovaleryl Chloride View Details
7,10-MeO-10-DAB View Details
N-((4-Chloromethyl)-2-thiozolyl)guanidine hydrochloride View Details
3-Pentanone manufacturer 3-Bromo-4-fluorobenzoic Acid manufacturer N-[4-(4-bromophenyl)phenyl]-4-phenyl-N-(4-phenylphenyl)aniline manufacturer (3-(Hydroxymethyl)-4-methoxyphenyl)boronic acid Cas:908142-03-0 manufacturer Dibromomethane manufacturer